October 9, 2021
Migraine significantly worsens sleep quality, architecture
- /
September 28, 2021 Individuals with migraine had much poorer subjective sleep quality and altered sleep architecture vs. healthy individuals, according…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
October 8, 2021
1 Year of Ocrevus Not Linked to Higher Risk of Brain Infection PML
- /
- /
By Steve Bryson PhD on Oct 07, 2021 One year of Ocrevus (ocrelizumab) treatment does not increase the risk for a rare…
October 8, 2021
Depression worsens vascular, mortality outcomes in MS
- /
- /
- /
- /
Source: Adobe Stock September 13, 2021 Depression appeared to increase risk for incident vascular disease and mortality among individuals with…
October 8, 2021
Newer MS diagnostic criteria show ‘prognostic improvement’
- /
- /
September 27, 2021 Researchers observed a continuous decrease in the time to MS diagnosis and treatment initiation across diagnostic criteria…
October 8, 2021
Rituximab, ocrelizumab pose risks in patients with MS and COVID-19
- /
- /
October 07, 2021 Rituximab and ocrelizumab appeared to increase risk for adverse outcomes among patients with MS and COVID-19, according…
October 7, 2021
Research News: Hospital Visits for People With MS Rise as Temperatures Increase, Study Finds
- /
Medically reviewed by Evelyn O. Berman, M.D. Article written by Torrey Kim October 05, 2021 In a recent retrospective study, researchers analyzed…
October 4, 2021
JC Virus Mutations May Predict Rare Brain Infection Linked to Tysabri
- /
- /
By Steve Bryson PhD on Oct 04, 2021 Mutations in the John Cunningham virus may serve as an early predictor…
October 1, 2021
Depression Can Be a Killer for People With MS
- /
- /
Depression and multiple sclerosis (MS) tend to travel together, new research finds, and when they do the chances of…
October 1, 2021
Hydroxychloroquine for Primary Progressive Multiple Sclerosis
- /
Abstract Objective: Primary progressive multiple sclerosis (PPMS) does not respond well to immunomodulatory or immunosuppressive treatment. Chronic activation of microglia…
September 29, 2021
Black People Undergoing MS Treatment Can Benefit From COVID Vaccines
- /
- /
- /
New research may be a determining factor for Black multiple sclerosis (MS), who often experience different symptoms than those of…
